Advances in glomerular diseases (GDs) from ASN 2025 include 52-week results on pegcetacoplan, data on emerging therapies, and GD outcomes across the lifespan, as reported by Dr Andrew Bomback.

Ethicist Art Caplan discusses a recent case highlighting the need for a deeper understanding of patient motivations when making ethical decisions.

A young radiographer’s life derails after an MRI reveals MS. His journey, from relapses to stem cell therapy, set him on a path to become an MD with a unique mindset for patient care.

Vericiguat Not the VICTOR in Heart Failure Drug Competition

Ethicist Art Caplan discusses insurance coverage and ethical questions related to a highly publicized lung transplant case.

Dr Kaitlin Sanzone discusses tips and tricks to be efficient on night shift.

Earlier detection of cardiac amyloidosis should improve patient outcomes, researchers say.

From smart cells to artificial hearts, Robert Langer predicts synthetic biology will continue to reshape medical treatments and procedures.

Robert Langer, ScD, director of the Langer Laboratory at the Massachusetts Institute of Technology, envisions future advances in biomedical engineering.

Studies on stem cell therapy, GLP-1 drugs, and a new infusion pump are discussed by Professor Diener in this update on movement disorders.